BRAF and non-small cell lung carcinoma: On a large group of patients with non-small-cell lung cancer, Mezequita investigated the relationship between the intensity of radon exposure and the occurrence of specific types of mutations such as EGFR, BRAF, KRAS and HER2, as well as ALK and ROS1 rearrangements.